DV
Dividend Vision

BGM Stock — Qilian International Holding Group Limited

Qilian International Holding Group Limited (BGM)

Updated November 9, 2026.

BGM is a stock. Total return is -99.4% over the past 5.8 years, 213.9 points behind SPY at 114.5%.

Qilian International Holding Group Limited operates as a pharmaceutical and chemical company in China, producing oxytetracycline products for veterinary and human use, traditional Chinese medicine derivatives, licorice products, heparin ingredients, sausage casings, and fertilizers, while also developing an AI-driven commercialization platform. The company does not currently distribute to shareholders. This security may appeal to investors seeking equity exposure to Chinese pharmaceutical and specialty chemical manufacturers.

BGM dividend yield and income

Price as of 2026-11-09.

The ex-dividend date is 02/27/2023. The payment date is 03/06/2023.

1 recorded distributions
Ex-dateAs paidPer current shareChange from previous payment
2023-02-27$0.05$7.5—
2023 total—$7.5—

BGM performance versus SPY

Total return is -99.4% over the past 5.8 years, 213.9 points behind SPY at 114.5%. Over the past year its total return — price change plus distributions reinvested — is -97.0%. Its deepest 1-year drawdown was 97.5%.

WindowTotal returnCAGR
1M-19.9%—
3M-4.5%—
6M-2.0%—
YTD-92.2%—
1Y-97.0%—
2Y CAGR—-80.20%
3Y CAGR—-47.80%
5Y CAGR—-56.30%
Since inception 2021-01-12 · 5.8 years-99.4%-58.80%

BGM key facts

Asset type
Stock
Asset class
Equity
Inception date
01/12/2021
Distribution frequency
None
Last close
$8.61 (as of 2026-11-09)
Market cap
$109,238,901
Average volume
1,564
Ex-dividend date
02/27/2023
Payment date
03/06/2023
Beta
1.457
Payout ratio
0.0%
EPS
-$4.80

How Dividend Vision calculates returns

Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BGM risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 97.5%.

Who may consider BGM — and who may not

It is a weaker fit for investors who need monthly cash flow (BGM does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BGM

Tagged: Healthcare, Dividend.

Frequently asked questions

Does BGM pay monthly?

No. BGM does not currently distribute.

When does BGM pay a dividend?

BGM does not currently distribute. The ex-dividend date is 02/27/2023. The payment date is 03/06/2023.

How has BGM performed?

Total return is -99.4% over the past 5.8 years, 213.9 points behind SPY at 114.5%. Over the past year its total return — price change plus distributions reinvested — is -97.0%. Its deepest 1-year drawdown was 97.5%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.